InsiderClue
← All stocks

Cullinan Therapeutics, Inc.

CGEM Net buying
CIK 0001789972 #2364 in the set updated 17 Sep 2026
Bought (120 mo)
$51.62M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$35.72M
$702.60K on a plan · $6.75M straight out of an exercise
Sold at will
$28.27M
139 of 185 sales
Net
+$15.90M
+$23.35M against sales at will

By person

19 insiders · 213 transactions
12.0×

Nadim Ahmed holds 12.0 times base salary in stock. $8.43M of shares against $698.48K in salary for 2025.

Salary from the company's own proxy. The shares are what Nadim Ahmed last reported holding, valued at $21.57, the price Common Stock was last bought or sold at on the open market here, on 8 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
BVF PARTNERS L P/IL entity
10% owner
$21.30M (10)
—
+$21.30M
64,161
0.0997%
$1.38M
−98.5%
Lynx1 Capital Management LP entity
10% owner
$13.32M (8)
—
+$13.32M
8,963,500
13.93%
$193.34M
+26.4%
F2 Vision SCS
10% owner
—
$4.76M (7)
−$4.76M
1,255,963
1.95%
$27.09M
−56.9%
Michaelson Jennifer
Chief Scientific Officer
—
$4.71M (51) scheduled
−$4.71M
158,844
0.2468%
$3.43M
+537.2%
Jovan-Embiricos Morana
10% owner
$4.20M (2)
—
+$4.20M
312,565
0.4857%
$6.74M
—
Zawel Leigh
See Remarks
—
$3.09M (10)
−$3.09M
69,785
0.1084%
$1.51M
−53.4%
GADICKE ANSBERT
Director
$6.30M (1)
$8.85M (38)
−$2.55M
23,612,189
36.69%
$509.31M
+50.2%
Savill Corrine
Chief Business Officer
—
$2.54M (9) scheduled
−$2.54M
240,990
0.3745%
$5.20M
+24.8%
UBS Oncology Impact Fund L.P. entity
10% owner
$6.30M (1)
$7.77M (19)
−$1.47M
7,648,268
11.88%
$164.97M
—
F2 Bioscience I 2017 Ltd entity
10% owner
—
$1.30M (3)
−$1.30M
537,392
0.8350%
$11.59M
−15.9%
AHMED NADIM
President and CEO
$100.32K (1)
$794.17K (10)
−$693.85K
390,803
0.6073%
$8.43M
—
Trigilio Jeffrey
Chief Financial Officer
$47.25K (1)
$689.70K (13) scheduled
−$642.45K
133,919
0.2081%
$2.89M
—
Baeuerle Patrick
Chief Scientific Officer
—
$609.95K (2) scheduled
−$609.95K
417,434
0.6486%
$9.00M
+22.3%
Jones Jeffrey Alan
Chief Medical Officer
—
$309.61K (11)
−$309.61K
159,968
0.2486%
$3.45M
—
SUMER JACQUELYN L
Chief Legal Officer
—
$235.65K (11)
−$235.65K
130,559
0.2029%
$2.82M
+6,373%
Fenton Mary Kay
Chief Financial Officer
—
$59.90K (1)
−$59.90K
127,921
0.1988%
$2.76M
+6,293%
Hughes Owen
President and CEO
$52.50K (1)
—
+$52.50K
506,226
0.7866%
$10.92M
+0.5%
Ebeling Thomas
Director
—
—
—
186,653
0.2900%
$4.03M
+176.5%
Keane Raymond T
Chief Legal Officer
—
—
—
24,124
0.0375%
$520.35K
+1,385%

Individual transactions

213
Insider
Date
Role
Action
Shares
Price
Amount
Michaelson Jennifer
8 Sep 2026
Chief Scientific Officer
Sold after exercise
8,000
$21.57
$172.56K
Michaelson Jennifer
13 Aug 2026
Chief Scientific Officer
Sold after exercise
30,000
$20.26
$607.80K
Michaelson Jennifer
6 Jul 2026
Chief Scientific Officer
Sold after exercise
8,000
$17.82
$142.56K
Michaelson Jennifer
5 May 2026
Chief Scientific Officer
Sold after exercise
200
$15.58
$3.12K
Michaelson Jennifer
5 May 2026
Chief Scientific Officer
Sold after exercise
7,800
$14.60
$113.88K
Michaelson Jennifer
5 Mar 2026
Chief Scientific Officer
Sold after exercise
8,000
$15.68
$125.44K
Michaelson Jennifer
25 Feb 2026
Chief Scientific Officer
Sold on a plan
1,780
$14.14
$25.17K
SUMER JACQUELYN L
24 Feb 2026
Chief Legal Officer
Sell
3,601
$14.47
$52.11K
Jones Jeffrey Alan
24 Feb 2026
Chief Medical Officer
Sell
4,582
$14.47
$66.30K
AHMED NADIM
24 Feb 2026
President and CEO
Sell
13,515
$14.47
$195.56K
Michaelson Jennifer
24 Feb 2026
Chief Scientific Officer
Sold on a plan
3,601
$14.47
$52.11K
Michaelson Jennifer
23 Feb 2026
Chief Scientific Officer
Sold on a plan
1,752
$13.99
$24.51K
Fenton Mary Kay
20 Feb 2026
Chief Financial Officer
Sell
4,398
$13.62
$59.90K
AHMED NADIM
20 Feb 2026
President and CEO
Sell
16,381
$13.62
$223.11K
SUMER JACQUELYN L
20 Feb 2026
Chief Legal Officer
Sell
3,742
$13.62
$50.97K
Michaelson Jennifer
20 Feb 2026
Chief Scientific Officer
Sold after exercise
8,000
$14.30
$114.40K
Michaelson Jennifer
20 Feb 2026
Chief Scientific Officer
Sold after exercise
3,742
$13.62
$50.97K
Jones Jeffrey Alan
20 Feb 2026
Chief Medical Officer
Sell
4,982
$13.62
$67.85K
Michaelson Jennifer
12 Feb 2026
Chief Scientific Officer
Sell
416
$12.03
$5.00K
Michaelson Jennifer
22 Jan 2026
Chief Scientific Officer
Sold on a plan
4,000
$12.30
$49.20K
AHMED NADIM
23 Dec 2025
President and CEO
Sell
9,922
$10.01
$99.32K
Michaelson Jennifer
19 Dec 2025
Chief Scientific Officer
Sold on a plan
1,345
$10.01
$13.46K
Michaelson Jennifer
18 Dec 2025
Chief Scientific Officer
Sell
2,898
$9.67
$28.02K
Jones Jeffrey Alan
18 Dec 2025
Chief Medical Officer
Sell
4,632
$9.67
$44.79K
SUMER JACQUELYN L
18 Dec 2025
Chief Legal Officer
Sell
3,480
$9.67
$33.65K
Michaelson Jennifer
15 Dec 2025
Chief Scientific Officer
Sold on a plan
995
$11.90
$11.84K
Michaelson Jennifer
12 Dec 2025
Chief Scientific Officer
Sold on a plan
2,148
$12.38
$26.59K
Michaelson Jennifer
24 Nov 2025
Chief Scientific Officer
Sold on a plan
4,000
$12.30
$49.20K
Lynx1 Capital Management LP
28 Oct 2025
10% owner
Buy indirect
165,667
$8.40
$1.39M
Lynx1 Capital Management LP
17 Oct 2025
10% owner
Buy indirect
32,217
$7.84
$252.57K
Lynx1 Capital Management LP
16 Oct 2025
10% owner
Buy indirect
150,000
$8.86
$1.33M
Lynx1 Capital Management LP
15 Oct 2025
10% owner
Buy indirect
51,500
$7.94
$409.05K
Lynx1 Capital Management LP
14 Oct 2025
10% owner
Buy indirect
15,032
$7.59
$114.05K
Lynx1 Capital Management LP
10 Oct 2025
10% owner
Buy indirect
277,298
$7.36
$2.04M
Lynx1 Capital Management LP
9 Oct 2025
10% owner
Buy indirect
626,043
$6.70
$4.19M
Lynx1 Capital Management LP
8 Oct 2025
10% owner
Buy indirect
556,300
$6.46
$3.59M
SUMER JACQUELYN L
25 Feb 2025
Chief Legal Officer
Sell
3,756
$8.53
$32.04K
Michaelson Jennifer
25 Feb 2025
Chief Scientific Officer
Sell
3,756
$8.53
$32.04K
AHMED NADIM
25 Feb 2025
President and CEO
Sell
12,529
$8.53
$106.87K
Jones Jeffrey Alan
25 Feb 2025
Chief Medical Officer
Sell
4,895
$8.53
$41.75K
Michaelson Jennifer
6 Jan 2025
Chief Scientific Officer
Sold on a plan
4,000
$12.51
$50.04K
AHMED NADIM
24 Dec 2024
President and CEO
Sell
8,400
$11.87
$99.71K
SUMER JACQUELYN L
18 Dec 2024
Chief Legal Officer
Sell
3,482
$11.41
$39.73K
Jones Jeffrey Alan
18 Dec 2024
Chief Medical Officer
Sell
4,632
$11.41
$52.85K
Michaelson Jennifer
18 Dec 2024
Chief Scientific Officer
Sell
4,693
$11.41
$53.55K
Michaelson Jennifer
12 Dec 2024
Chief Scientific Officer
Sell
3,489
$12.52
$43.68K
Michaelson Jennifer
5 Nov 2024
Chief Scientific Officer
Sold on a plan
8,000
$15.64
$125.12K
Michaelson Jennifer
5 Sep 2024
Chief Scientific Officer
Sold on a plan
8,000
$18.09
$144.72K
Michaelson Jennifer
5 Jul 2024
Chief Scientific Officer
Sold on a plan
8,000
$16.33
$130.64K
Ebeling Thomas
10 Jun 2024
Director
Exercised, kept
18,450
$13.00
$239.85K
Michaelson Jennifer
7 May 2024
Chief Scientific Officer
Sold after exercise
5,606
$30.06
$168.52K
Michaelson Jennifer
6 May 2024
Chief Scientific Officer
Sold after exercise
20,277
$28.54
$578.71K
Michaelson Jennifer
6 May 2024
Chief Scientific Officer
Sold after exercise
37,723
$27.82
$1.05M
Savill Corrine
1 Feb 2024
Chief Business Officer
Sold after exercise
40,000
$16.18
$647.20K
Savill Corrine
29 Jan 2024
Chief Business Officer
Sold after exercise
40,000
$14.09
$563.60K
Savill Corrine
23 Jan 2024
Chief Business Officer
Sold after exercise
21,316
$12.46
$265.60K
Savill Corrine
22 Jan 2024
Chief Business Officer
Sold after exercise
4,125
$12.02
$49.58K
Savill Corrine
22 Jan 2024
Chief Business Officer
Sold after exercise
14,559
$12.18
$177.33K
AHMED NADIM
26 Dec 2023
President and CEO
Sell
4,272
$9.24
$39.47K
Michaelson Jennifer
21 Dec 2023
Chief Scientific Officer
Sell
1,145
$8.50
$9.73K
Trigilio Jeffrey
21 Dec 2023
Chief Financial Officer
Sell
1,920
$8.50
$16.32K
SUMER JACQUELYN L
21 Dec 2023
Chief Legal Officer
Sell
1,400
$8.50
$11.90K
Jones Jeffrey Alan
21 Dec 2023
Chief Medical Officer
Sell
1,860
$8.50
$15.81K
Trigilio Jeffrey
18 Dec 2023
Chief Financial Officer
Sell
398
$8.22
$3.27K
SUMER JACQUELYN L
18 Dec 2023
Chief Legal Officer
Sell
290
$8.22
$2.38K
Michaelson Jennifer
18 Dec 2023
Chief Scientific Officer
Sell
238
$8.22
$1.96K
Jones Jeffrey Alan
18 Dec 2023
Chief Medical Officer
Sell
386
$8.22
$3.17K
Michaelson Jennifer
12 Dec 2023
Chief Scientific Officer
Sell
1,068
$7.81
$8.34K
Trigilio Jeffrey
12 Dec 2023
Chief Financial Officer
Sell
1,926
$7.81
$15.04K
AHMED NADIM
28 Jun 2023
President and CEO
Sell
759
$11.40
$8.65K
SUMER JACQUELYN L
20 Jun 2023
Chief Legal Officer
Sell
291
$12.94
$3.77K
Trigilio Jeffrey
20 Jun 2023
Chief Financial Officer
Sell
399
$12.94
$5.16K
Michaelson Jennifer
20 Jun 2023
Chief Development Officer
Sell
238
$12.94
$3.08K
Jones Jeffrey Alan
20 Jun 2023
Chief Medical Officer
Sell
387
$12.94
$5.01K
Michaelson Jennifer
12 Jun 2023
Chief Development Officer
Sell
176
$13.11
$2.31K
Trigilio Jeffrey
12 Jun 2023
Chief Financial Officer
Sell
319
$13.11
$4.18K
Michaelson Jennifer
7 Jun 2023
Chief Development Officer
Sold after exercise
100
$12.40
$1.24K
Michaelson Jennifer
6 Jun 2023
Chief Development Officer
Sold after exercise
11,900
$12.31
$146.49K
AHMED NADIM
23 May 2023
President and CEO
Sell
707
$9.15
$6.47K
Trigilio Jeffrey
18 May 2023
Chief Financial Officer
Sell
399
$8.76
$3.50K
SUMER JACQUELYN L
18 May 2023
Chief Legal Officer
Sell
291
$8.76
$2.55K
Jones Jeffrey Alan
18 May 2023
Chief Medical Officer
Sell
394
$8.76
$3.45K
Michaelson Jennifer
18 May 2023
Chief Development Officer
Sell
239
$8.76
$2.09K
Trigilio Jeffrey
12 May 2023
Chief Financial Officer
Sell
347
$8.78
$3.05K
Michaelson Jennifer
12 May 2023
Chief Development Officer
Sell
193
$8.78
$1.69K
AHMED NADIM
25 Apr 2023
President and CEO
Sell
716
$10.59
$7.58K
SUMER JACQUELYN L
18 Apr 2023
Chief Legal Officer
Sell
290
$10.71
$3.11K
Michaelson Jennifer
18 Apr 2023
Chief Development Officer
Sell
238
$10.71
$2.55K
Trigilio Jeffrey
18 Apr 2023
Chief Financial Officer
Sell
398
$10.71
$4.26K
Jones Jeffrey Alan
18 Apr 2023
Chief Medical Officer
Sell
392
$10.71
$4.20K
Michaelson Jennifer
12 Apr 2023
Chief Development Officer
Sell
176
$10.22
$1.80K
Trigilio Jeffrey
12 Apr 2023
Chief Financial Officer
Sell
318
$10.22
$3.25K
AHMED NADIM
23 Mar 2023
President and CEO
Sell
706
$10.51
$7.42K
SUMER JACQUELYN L
20 Mar 2023
Chief Legal Officer
Sell
305
$11.32
$3.45K
Michaelson Jennifer
20 Mar 2023
Chief Development Officer
Sell
238
$11.32
$2.69K
Jones Jeffrey Alan
20 Mar 2023
Chief Medical Officer
Sell
390
$11.32
$4.41K
Trigilio Jeffrey
20 Mar 2023
Chief Financial Officer
Sell
399
$11.32
$4.52K
Michaelson Jennifer
25 Nov 2022
See Remarks
Sold after exercise
4,000
$13.30
$53.20K
Michaelson Jennifer
27 Sep 2022
See Remarks
Sold after exercise
4,000
$12.40
$49.60K
Michaelson Jennifer
8 Aug 2022
Chief Development Officer
Sold after exercise
1,385
$15.01
$20.79K
F2 Vision SCS
4 Aug 2022
10% owner
Sell
25,989
$14.31
$371.79K
F2 Vision SCS
3 Aug 2022
10% owner
Sell
19,129
$14.24
$272.33K
F2 Vision SCS
2 Aug 2022
10% owner
Sell
4,792
$14.10
$67.55K
Michaelson Jennifer
25 Jul 2022
Chief Development Officer
Sold after exercise
8,000
$14.51
$116.08K
Savill Corrine
19 Jul 2022
Acting Chief Business Officer
Sell
14,958
$15.22
$227.66K
Savill Corrine
18 Jul 2022
Acting Chief Business Officer
Sell
5,042
$15.06
$75.93K
Savill Corrine
11 Jul 2022
Acting Chief Business Officer
Sell
200
$13.85
$2.77K
Savill Corrine
11 Jul 2022
Acting Chief Business Officer
Sell
39,800
$13.33
$530.53K
Jovan-Embiricos Morana
24 Jun 2022
10% owner
Exercised, kept
35,529
$4.30
$152.77K
Jovan-Embiricos Morana
24 Jun 2022
10% owner
Exercised, kept
104,845
$4.30
$450.83K
F2 Bioscience I 2017 Ltd
23 Jun 2022
10% owner
Sell
29,631
$13.00
$385.31K
F2 Bioscience I 2017 Ltd
22 Jun 2022
10% owner
Sell
49,953
$12.70
$634.58K
F2 Bioscience I 2017 Ltd
21 Jun 2022
10% owner
Sell
22,319
$12.77
$284.93K
AHMED NADIM
6 Jun 2022
President and CEO
Buy
8,090
$12.40
$100.32K
BVF PARTNERS L P/IL
1 Jun 2022
10% owner
Buy
44,746
$11.00
$492.18K
BVF PARTNERS L P/IL
1 Jun 2022
10% owner
Buy
301,009
$11.00
$3.31M
BVF PARTNERS L P/IL
1 Jun 2022
10% owner
Buy
405,641
$11.00
$4.46M
F2 Vision SCS
16 May 2022
10% owner
Sell
35,158
$11.23
$394.83K
BVF PARTNERS L P/IL
13 May 2022
10% owner
Buy
17,744
$9.14
$162.09K
BVF PARTNERS L P/IL
13 May 2022
10% owner
Buy
38,558
$9.14
$352.23K
BVF PARTNERS L P/IL
13 May 2022
10% owner
Buy
53,598
$9.14
$489.62K
F2 Vision SCS
13 May 2022
10% owner
Sell
34,189
$10.48
$358.33K
F2 Vision SCS
13 May 2022
10% owner
Sell
85,319
$9.96
$850.04K
BVF PARTNERS L P/IL
12 May 2022
10% owner
Buy
457,001
$9.06
$4.14M
BVF PARTNERS L P/IL
12 May 2022
10% owner
Buy
542,999
$9.06
$4.92M
F2 Vision SCS
12 May 2022
10% owner
Sell
264,072
$9.25
$2.44M
BVF PARTNERS L P/IL
1 Apr 2022
10% owner
Buy
9,402
$10.75
$101.07K
BVF PARTNERS L P/IL
1 Apr 2022
10% owner
Buy
266,598
$10.75
$2.87M
Michaelson Jennifer
18 Oct 2021
See Remarks
Sold after exercise
400
$23.61
$9.44K
Michaelson Jennifer
18 Oct 2021
See Remarks
Sold after exercise
204
$22.40
$4.57K
Michaelson Jennifer
18 Oct 2021
See Remarks
Sold after exercise
3,396
$21.10
$71.66K
Zawel Leigh
15 Oct 2021
See Remarks
Sell
19,574
$25.00
$489.35K
Trigilio Jeffrey
15 Oct 2021
Chief Financial Officer
Sold after exercise
8,000
$25.00
$200.00K
Zawel Leigh
7 Oct 2021
See Remarks
Sell
1,079
$25.00
$26.98K
Zawel Leigh
20 Sep 2021
See Remarks
Sell
7,468
$25.16
$187.89K
Michaelson Jennifer
20 Sep 2021
See Remarks
Sold after exercise
800
$25.20
$20.16K
Michaelson Jennifer
20 Sep 2021
See Remarks
Sold after exercise
3,200
$24.34
$77.89K
GADICKE ANSBERT
16 Sep 2021
Director
Sell indirect
3,124
$29.06
$90.78K
GADICKE ANSBERT
16 Sep 2021
Director
Sell
432
$29.06
$12.55K
UBS Oncology Impact Fund L.P.
16 Sep 2021
10% owner
Sell
3,124
$29.06
$90.78K
GADICKE ANSBERT
15 Sep 2021
Director
Sell indirect
6,425
$29.16
$187.35K
GADICKE ANSBERT
15 Sep 2021
Director
Sell
888
$29.16
$25.89K
UBS Oncology Impact Fund L.P.
15 Sep 2021
10% owner
Sell
6,425
$29.16
$187.35K
GADICKE ANSBERT
14 Sep 2021
Director
Sell indirect
7,106
$29.17
$207.28K
GADICKE ANSBERT
14 Sep 2021
Director
Sell
982
$29.17
$28.64K
UBS Oncology Impact Fund L.P.
14 Sep 2021
10% owner
Sell
7,106
$29.17
$207.28K
GADICKE ANSBERT
13 Sep 2021
Director
Sell indirect
3,595
$29.10
$104.61K
GADICKE ANSBERT
13 Sep 2021
Director
Sell
497
$29.10
$14.46K
UBS Oncology Impact Fund L.P.
13 Sep 2021
10% owner
Sell
3,595
$29.10
$104.61K
GADICKE ANSBERT
10 Sep 2021
Director
Sell indirect
5,931
$29.04
$172.24K
GADICKE ANSBERT
10 Sep 2021
Director
Sell
820
$29.04
$23.81K
UBS Oncology Impact Fund L.P.
10 Sep 2021
10% owner
Sell
5,931
$29.04
$172.24K
GADICKE ANSBERT
9 Sep 2021
Director
Sell indirect
13,727
$29.35
$402.89K
GADICKE ANSBERT
9 Sep 2021
Director
Sell
1,898
$29.35
$55.71K
UBS Oncology Impact Fund L.P.
9 Sep 2021
10% owner
Sell
13,727
$29.35
$402.89K
GADICKE ANSBERT
8 Sep 2021
Director
Sell indirect
10,842
$29.11
$315.61K
GADICKE ANSBERT
8 Sep 2021
Director
Sell
1,499
$29.11
$43.64K
UBS Oncology Impact Fund L.P.
8 Sep 2021
10% owner
Sell
10,842
$29.11
$315.61K
Trigilio Jeffrey
8 Sep 2021
Chief Financial Officer
Sold after exercise
9,513
$28.85
$274.45K
Trigilio Jeffrey
8 Sep 2021
Chief Financial Officer
Sold after exercise
5,487
$27.83
$152.70K
Baeuerle Patrick
8 Sep 2021
See Remarks
Sold after exercise
11,000
$28.45
$312.95K
Zawel Leigh
7 Sep 2021
See Remarks
Sell
28,118
$28.95
$814.02K
GADICKE ANSBERT
7 Sep 2021
Director
Sell indirect
25,067
$29.04
$727.95K
GADICKE ANSBERT
7 Sep 2021
Director
Sell
3,465
$29.04
$100.62K
UBS Oncology Impact Fund L.P.
7 Sep 2021
10% owner
Sell
25,067
$29.04
$727.95K
GADICKE ANSBERT
3 Sep 2021
Director
Sell indirect
12,731
$29.60
$376.84K
GADICKE ANSBERT
3 Sep 2021
Director
Sell
1,760
$29.60
$52.10K
UBS Oncology Impact Fund L.P.
3 Sep 2021
10% owner
Sell
12,731
$29.60
$376.84K
GADICKE ANSBERT
2 Sep 2021
Director
Sell indirect
15,757
$29.46
$464.20K
GADICKE ANSBERT
2 Sep 2021
Director
Sell
2,178
$29.46
$64.16K
UBS Oncology Impact Fund L.P.
2 Sep 2021
10% owner
Sell
15,757
$29.46
$464.20K
GADICKE ANSBERT
1 Sep 2021
Director
Sell indirect
5,714
$29.47
$168.39K
GADICKE ANSBERT
1 Sep 2021
Director
Sell
790
$29.47
$23.28K
UBS Oncology Impact Fund L.P.
1 Sep 2021
10% owner
Sell
5,714
$29.47
$168.39K
GADICKE ANSBERT
31 Aug 2021
Director
Sell indirect
1,553
$30.14
$46.81K
GADICKE ANSBERT
31 Aug 2021
Director
Sell
215
$30.14
$6.48K
GADICKE ANSBERT
31 Aug 2021
Director
Sell indirect
1,285
$29.43
$37.82K
GADICKE ANSBERT
31 Aug 2021
Director
Sell
177
$29.43
$5.21K
UBS Oncology Impact Fund L.P.
31 Aug 2021
10% owner
Sell
1,553
$30.14
$46.81K
UBS Oncology Impact Fund L.P.
31 Aug 2021
10% owner
Sell
1,285
$29.43
$37.82K
UBS Oncology Impact Fund L.P.
30 Aug 2021
10% owner
Sell
31,001
$29.30
$908.33K
GADICKE ANSBERT
30 Aug 2021
Director
Sell indirect
31,001
$29.30
$908.33K
GADICKE ANSBERT
30 Aug 2021
Director
Sell
4,285
$29.30
$125.55K
UBS Oncology Impact Fund L.P.
27 Aug 2021
10% owner
Sell
13,357
$29.09
$388.56K
GADICKE ANSBERT
27 Aug 2021
Director
Sell indirect
13,357
$29.09
$388.56K
GADICKE ANSBERT
27 Aug 2021
Director
Sell
1,846
$29.09
$53.70K
GADICKE ANSBERT
25 Aug 2021
Director
Sell indirect
1,713
$29.09
$49.83K
GADICKE ANSBERT
25 Aug 2021
Director
Sell
237
$29.09
$6.89K
UBS Oncology Impact Fund L.P.
25 Aug 2021
10% owner
Sell
1,713
$29.09
$49.83K
GADICKE ANSBERT
24 Aug 2021
Director
Sell indirect
50,882
$29.48
$1.50M
GADICKE ANSBERT
24 Aug 2021
Director
Sell
7,025
$29.48
$207.10K
UBS Oncology Impact Fund L.P.
24 Aug 2021
10% owner
Sell
50,822
$29.48
$1.50M
Zawel Leigh
23 Aug 2021
See Remarks
Sell
28,118
$29.00
$815.42K
GADICKE ANSBERT
23 Aug 2021
Director
Sell indirect
53,359
$29.11
$1.55M
GADICKE ANSBERT
23 Aug 2021
Director
Sell
7,376
$29.11
$214.72K
UBS Oncology Impact Fund L.P.
23 Aug 2021
10% owner
Sell
53,359
$29.11
$1.55M
Michaelson Jennifer
18 Aug 2021
See Remarks
Sold after exercise
1,137
$28.07
$31.92K
Michaelson Jennifer
18 Aug 2021
See Remarks
Sold after exercise
2,863
$27.50
$78.73K
GADICKE ANSBERT
11 Aug 2021
Director
Sell indirect
2,510
$29.05
$72.92K
GADICKE ANSBERT
11 Aug 2021
Director
Sell
347
$29.05
$10.08K
UBS Oncology Impact Fund L.P.
11 Aug 2021
10% owner
Sell
2,510
$29.05
$72.92K
Zawel Leigh
10 Aug 2021
See Remarks
Sell
1,817
$28.49
$51.77K
Zawel Leigh
10 Aug 2021
See Remarks
Sell
3,191
$27.34
$87.24K
Zawel Leigh
10 Aug 2021
See Remarks
Sell
1,906
$26.50
$50.51K
Baeuerle Patrick
10 Aug 2021
See Remarks
Sold after exercise
11,000
$27.00
$297.00K
Zawel Leigh
9 Aug 2021
See Remarks
Sell
1,700
$27.11
$46.09K
Zawel Leigh
9 Aug 2021
See Remarks
Sell
19,504
$26.52
$517.25K
Trigilio Jeffrey
12 Jan 2021
Chief Financial Officer
Buy
2,250
$21.00
$47.25K
Hughes Owen
12 Jan 2021
President and CEO
Buy
2,500
$21.00
$52.50K
Jovan-Embiricos Morana
12 Jan 2021
Director
Buy indirect
104,762
$21.00
$2.20M
Jovan-Embiricos Morana
12 Jan 2021
Director
Buy indirect
95,238
$21.00
$2.00M
GADICKE ANSBERT
12 Jan 2021
Director
Buy indirect
300,000
$21.00
$6.30M
UBS Oncology Impact Fund L.P.
12 Jan 2021
10% owner
Buy
300,000
$21.00
$6.30M

What was left out

Form 4 filings counted 220
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 21
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 34
Sales at will 139
Transactions with no price 0
Shares from compensation/vesting 31,067,955
Sales filed before the plan box existed 81
History held since 11 Jan 2021